GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » EV-to-FCF

Hunan Hansen Pharmaceutical Co (SZSE:002412) EV-to-FCF : 16.86 (As of Dec. 15, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hunan Hansen Pharmaceutical Co's Enterprise Value is ¥3,040.2 Mil. Hunan Hansen Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥180.3 Mil. Therefore, Hunan Hansen Pharmaceutical Co's EV-to-FCF for today is 16.86.

The historical rank and industry rank for Hunan Hansen Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

SZSE:002412' s EV-to-FCF Range Over the Past 10 Years
Min: -2102.77   Med: 31.23   Max: 502.75
Current: 16.72

During the past 13 years, the highest EV-to-FCF of Hunan Hansen Pharmaceutical Co was 502.75. The lowest was -2102.77. And the median was 31.23.

SZSE:002412's EV-to-FCF is ranked better than
66.55% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs SZSE:002412: 16.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), Hunan Hansen Pharmaceutical Co's stock price is ¥6.62. Hunan Hansen Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.449. Therefore, Hunan Hansen Pharmaceutical Co's PE Ratio (TTM) for today is 14.74.


Hunan Hansen Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Hunan Hansen Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Hansen Pharmaceutical Co EV-to-FCF Chart

Hunan Hansen Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.68 99.53 -189.74 22.10 22.99

Hunan Hansen Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.82 22.99 28.06 20.87 15.55

Competitive Comparison of Hunan Hansen Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Hansen Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Hansen Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Hansen Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hunan Hansen Pharmaceutical Co's EV-to-FCF falls into.



Hunan Hansen Pharmaceutical Co EV-to-FCF Calculation

Hunan Hansen Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3040.156/180.273
=16.86

Hunan Hansen Pharmaceutical Co's current Enterprise Value is ¥3,040.2 Mil.
Hunan Hansen Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥180.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Hansen Pharmaceutical Co  (SZSE:002412) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Hunan Hansen Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6.62/0.449
=14.74

Hunan Hansen Pharmaceutical Co's share price for today is ¥6.62.
Hunan Hansen Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.449.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hunan Hansen Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Hansen Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000
Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.
Executives
Luo Yong Qing Directors, executives
Liu Zheng Qing Directors, executives
Liu Ling An Director
Fu Jian Jun Executives
Liu Na Xin Independent director
Liu Hou Yao Directors, Directors, and Executives
He San Xing Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines